Treatment Eligibility and Outcomes in Elderly Patients with Chronic Hepatitis C: Results from the VA HCV-001 Study
Authors:
- Judith I. TsuiJTJudith I. Tsui
- For the VA HCV-001 Study groupFGFor the VA HCV-001 Study group
- 1 September 2007
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 53 (3) , 809-814
Abstract
Objectives We undertook this study to determine if treatment candidacy and outcomes were similar between elderly and non-elderly patients. Methods This was a prospective cohort study that screened 4,025 patients with chronic hepatitis C for HCV antiviral treatment at 24 Veterans Affairs Medical Centers throughout the country. We used multivariable logistic regression to determine whether there was an independent association between being elderly (age > 60 vs. ≤ 60) and (1) being considered a treatment candidate by clinician, and (2) achieving sustained virologic response if treated. Results 364 of the 4,025 patients (9%) were over the age of 60. Only 25% of patients over the age of 60 were considered to be treatment candidates by the evaluating clinician, and only 10% were started on treatment. After adjustment for potential confounders, older age remained associated with a lower likelihood of being considered a treatment candidate (adjusted OR = 0.43; 95% CI: 0.30–0.61). Although based on a small sample of elderly treated patients (n = 35), being elderly did not appear to be associated with a lower likelihood of achieving SVR (adjusted OR = 1.54; 95% CI: 0.46–5.15). Conclusion Among veterans over the age of 60 with chronic hepatitis C who are referred for treatment, relatively few are considered treatment candidates and an even smaller number are ultimately treated. After adjusting for co-morbidities, age remains a strong predictor of not being a treatment candidate. In contrast, older age does not seem to adversely affect treatment outcomes and side effects.Keywords
This publication has 17 references indexed in Scilit:
- Efficacy of Interferon Therapy in Elderly Patients with Chronic Hepatitis CIntervirology, 2006
- Black patients with chronic hepatitis C have a lower sustained viral response rate than non‐Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*Journal of Viral Hepatitis, 2005
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Fibrosis and disease progression in hepatitis CHepatology, 2002
- Natural history of chronic hepatitis CHepatology, 2002
- Natural history of chronic hepatitis CHepatology, 2002
- Fibrosis and disease progression in hepatitis CHepatology, 2002
- LIVER DISEASE IN THE ELDERLYGastroenterology Clinics of North America, 2001
- Treatment of Hepatitis C Virus in Elderly Persons With InterferonThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 1995
- Interferon therapy for patients more than 60 years of age with chronic hepatitis CJournal of Gastroenterology and Hepatology, 1995